Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Emerging Role of SGLT-2 Inhibitors for the Treatment of ObesityDrugs (New York, N.Y.), 2019-02, Vol.79 (3), p.219-230 [Peer Reviewed Journal]The Author(s) 2019 ;Copyright Springer Nature B.V. Feb 2019 ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-019-1057-0 ;PMID: 30701480Full text available |
|
2 |
Material Type: Article
|
Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future PerspectivesDrugs (New York, N.Y.), 2017-08, Vol.77 (12), p.1281-1294 [Peer Reviewed Journal]The Author(s) 2017 ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-017-0777-2 ;PMID: 28612233Full text available |
|
3 |
Material Type: Article
|
Marine Natural Products: A Source of Novel Anticancer DrugsMarine drugs, 2019-08, Vol.17 (9), p.491 [Peer Reviewed Journal]2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1660-3397 ;EISSN: 1660-3397 ;DOI: 10.3390/md17090491 ;PMID: 31443597Full text available |
|
4 |
Material Type: Article
|
Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related ChangesTheranostics, 2017-01, Vol.7 (16), p.3824-3841 [Peer Reviewed Journal]Ivyspring International Publisher 2017 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.19890 ;PMID: 29109780Full text available |
|
5 |
Material Type: Article
|
Adverse outcome pathways: opportunities, limitations and open questionsArchives of toxicology, 2017-11, Vol.91 (11), p.3477-3505 [Peer Reviewed Journal]Springer-Verlag GmbH Germany 2017 ;Archives of Toxicology is a copyright of Springer, (2017). All Rights Reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0340-5761 ;ISSN: 1432-0738 ;EISSN: 1432-0738 ;DOI: 10.1007/s00204-017-2045-3 ;PMID: 29051992Full text available |
|
6 |
Material Type: Article
|
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future DevelopmentsThe AAPS journal, 2017-11, Vol.20 (1), p.4-4, Article 4 [Peer Reviewed Journal]The Author(s) 2017 ;ISSN: 1550-7416 ;EISSN: 1550-7416 ;DOI: 10.1208/s12248-017-0161-x ;PMID: 29181807Full text available |
|
7 |
Material Type: Article
|
Microdialysis as an Important Technique in Systems Pharmacology—a Historical and Methodological ReviewThe AAPS journal, 2017-09, Vol.19 (5), p.1294-1303 [Peer Reviewed Journal]The Author(s) 2017 ;ISSN: 1550-7416 ;EISSN: 1550-7416 ;DOI: 10.1208/s12248-017-0108-2 ;PMID: 28762127Full text available |
|
8 |
Material Type: Article
|
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB DrugsClinical pharmacokinetics, 2021-06, Vol.60 (6), p.685-710 [Peer Reviewed Journal]The Author(s) 2021 ;Copyright Springer Nature B.V. Jun 2021 ;ISSN: 0312-5963 ;ISSN: 1179-1926 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-021-00997-0 ;PMID: 33674941Full text available |
|
9 |
Material Type: Article
|
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of toxicology, 2013-08, Vol.87 (8), p.1315-1530 [Peer Reviewed Journal]The Author(s) 2013 ;Springer-Verlag Berlin Heidelberg 2013 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0340-5761 ;EISSN: 1432-0738 ;DOI: 10.1007/s00204-013-1078-5 ;PMID: 23974980Full text available |
|
10 |
Material Type: Article
|
Current Evidence on Abuse and Misuse of GabapentinoidsDrug safety, 2020-12, Vol.43 (12), p.1235-1254 [Peer Reviewed Journal]The Author(s) 2020 ;Copyright Springer Nature B.V. Dec 2020 ;ISSN: 0114-5916 ;ISSN: 1179-1942 ;EISSN: 1179-1942 ;DOI: 10.1007/s40264-020-00985-6 ;PMID: 32857333Full text available |
|
11 |
Material Type: Article
|
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory DiseasesDrugs (New York, N.Y.), 2020, Vol.80 (10), p.1039-1040 [Peer Reviewed Journal]Springer Nature Switzerland AG 2020 ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-020-01333-9 ;PMID: 32488813Full text available |
|
12 |
Material Type: Article
|
Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and TreatmentAmerican journal of clinical dermatology, 2018-02, Vol.19 (1), p.51-66 [Peer Reviewed Journal]The Author(s) 2017 ;Copyright Springer Science & Business Media Feb 2018 ;ISSN: 1175-0561 ;ISSN: 1179-1888 ;EISSN: 1179-1888 ;DOI: 10.1007/s40257-017-0313-x ;PMID: 28815464Full text available |
|
13 |
Material Type: Article
|
Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statementArchives of toxicology, 2017-02, Vol.91 (2), p.1001-1006 [Peer Reviewed Journal]The Author(s) 2016 ;Archives of Toxicology is a copyright of Springer, 2017. ;ISSN: 0340-5761 ;ISSN: 1432-0738 ;EISSN: 1432-0738 ;DOI: 10.1007/s00204-016-1866-9 ;PMID: 27714423Full text available |
|
14 |
Material Type: Article
|
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myelomaInvestigational new drugs, 2020-10, Vol.38 (5), p.1448-1453 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0167-6997 ;ISSN: 1573-0646 ;EISSN: 1573-0646 ;DOI: 10.1007/s10637-020-00915-4 ;PMID: 32125598Full text available |
|
15 |
Material Type: Article
|
Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA HypothesisNeurotoxicity research, 2021-02, Vol.39 (1), p.81-106 [Peer Reviewed Journal]The Author(s) 2021 ;ISSN: 1029-8428 ;ISSN: 1476-3524 ;EISSN: 1476-3524 ;DOI: 10.1007/s12640-020-00302-0Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-IsobutyrylfentanylThe AAPS journal, 2017-07, Vol.19 (4), p.1102-1122 [Peer Reviewed Journal]American Association of Pharmaceutical Scientists 2017 ;ISSN: 1550-7416 ;EISSN: 1550-7416 ;DOI: 10.1208/s12248-017-0070-z ;PMID: 28382544Full text available |
|
17 |
Material Type: Article
|
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of ClearanceClinical pharmacokinetics, 2019-01, Vol.58 (1), p.39-52 [Peer Reviewed Journal]The Author(s) 2018. corrected publication 2018 ;Copyright Springer Nature B.V. Jan 2019 ;The Author(s) 2018, corrected publication 2018 ;ISSN: 0312-5963 ;ISSN: 1179-1926 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-018-0659-0 ;PMID: 29675639Full text available |
|
18 |
Material Type: Article
|
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative ReviewAdvances in therapy, 2020-07, Vol.37 (7), p.3112-3128 [Peer Reviewed Journal]The Author(s) 2020 ;ISSN: 0741-238X ;ISSN: 1865-8652 ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-020-01391-1Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cellsArchives of toxicology, 2018-05, Vol.92 (5), p.1729-1739 [Peer Reviewed Journal]The Author(s) 2018 ;Archives of Toxicology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0340-5761 ;ISSN: 1432-0738 ;EISSN: 1432-0738 ;DOI: 10.1007/s00204-018-2181-4 ;PMID: 29502166Full text available |
|
20 |
Material Type: Article
|
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory DiseasesDrugs (New York, N.Y.), 2020-02, Vol.80 (2), p.99-113 [Peer Reviewed Journal]The Author(s) 2020 ;Copyright Springer Nature B.V. Feb 2020 ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-020-01256-5 ;PMID: 32002851Full text available |